Table 3.

Cox propotional hazards regression analyses for recipient death and graft failure in the PS-matched cohort

	Recipient death		Graft failure
	HR (95% CI)	P	HR (95% CI)	P
Recipient factor
Anti-HCV	1.50 (1.28–1.75)	<0.01	1.26 (1.08–1.47)	<0.01
Age (year)	1.04 (1.02–1.05)	<0.01	0.98 (0.98–0.99)	<0.01
Male	1.10 (0.91–1.32)	0.33	1.05 (0.88–1.25)	0.62
BMI (kg/m2)	1.00 (0.98–1.02)	0.96	1.00 (0.99–1.02)	0.68
African American	0.93 (0.78–1.11)	0.43	1.56 (1.31–1.85)	<0.01
Diabetes mellitus	1.34 (1.04–1.73)	0.02	0.97 (0.73–1.29)	0.83
Hypertension	1.13 (0.87–1.47)	0.35	1.00 (0.79–1.27)	0.99
Length of time on dialysis (year)	1.08 (1.05–1.12)	<0.01	0.99 (0.97–1.02)	0.62
Primary kidney disease
Hypertensive nephropathy	1.11 (0.54–2.28)	0.77	0.86 (0.49–1.53)	0.62
Diabetic nephropathy	1.35 (0.64–2.82)	0.43	0.88 (0.48–1.63)	0.69
Glomerulonephritis/nephropathy	0.88 (0.42–1.85)	0.74	0.91 (0.52–1.62)	0.76
Polycystic kidney disease	0.58 (0.25–1.34)	0.20	0.60 (0.30–1.21)	0.15
Others	1.16 (0.54–2.50)	0.70	0.97 (0.52–1.79)	0.91
Donor factor
Age (year)	1.01 (1.00–1.01)	<0.01	1.02 (1.01–1.02)	<0.01
Male	1.01 (0.86–1.19)	0.90	0.78 (0.60–1.01)	0.06
Deceased donor	1.64 (1.09–2.44)	0.02	1.78 (1.43–2.23)	<0.01
Transplant factor
No. of HLA mismatches
0–1	ref		ref
2~4	1.22 (0.90–1.65)	0.21	1.87 (1.31–2.65)	<0.01
5~6	1.50 (1.11–2.02)	<0.01	1.98 (1.40–2.82)	<0.01
Cold ischemic time
≤24 hours	ref		ref
>24 hours	0.99 (0.80–1.22)	0.90	0.88 (0.71–1.08)	0.22